Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force

Keyphrases

• Clinical Meaningfulness 100%
• Alzheimer's Disease Clinical Trials 100%
• Clinically Significant 66%
• Alzheimer's Disease 33%
• Change Score 33%
• Evidence-based 33%
• Clinical Practice 33%
• Disease-modifying Therapy 33%
• Boston 33%
• Reimbursement 33%
• Clinical Trial Results 33%
• State-of-the-art Knowledge 33%
• Emerging Therapies 33%
• Patient Partner 33%
• Clinical Outcome Assessment 33%
• Study Partner 33%
• Absolute Size 33%
• Long-term Cohort Study 33%
• Anti-amyloid Monoclonal Antibody 33%

Neuroscience

• Alzheimer's Disease 100%
• Monoclonal Antibody 50%
• Longitudinal Study 50%
• Decision-Making 50%
• Amyloid Protein 50%